Contract manufacturer Pharmstandard inked a license-and-manufacturing deal with France's Solvay Pharma. In the deal's first phase, Pharmstandard will use imported Solvay compounds to formulate and package two drugs, Imudon and IRS 19, in Russia. Next, Pharmstandard will take on manufacturing of the compounds itself. Report